Racial disparities in readmissions higher at 'minority-serving' hospitals

May 20, 2010

Racial disparities in readmissions for heart failure are mainly seen at the site at which care is provided, researchers report.

Using national Medicare data from 2006-07, researchers designated hospitals as "minority-serving" based on the proportion of black patients treated. In the study, 40 percent of all black patients and 5 percent of all white patients were cared for at minority-serving hospitals.

The researchers found:

  • Overall, black patients had slightly higher 30-day readmission rates (24.1 percent) than white patients (23.3 percent).
  • At minority-serving hospitals, black patients had slightly higher readmission rates than white patients (26.2 percent versus 25.1 percent).
  • At non-minority-serving hospitals, there were no disparities in readmissions (23.3 percent versus 23.1percent).
    Heart failure is the most common cause of hospitalizations and readmissions in the program. Improving efforts at poor-performing, minority-serving hospitals could increase quality of care for all patients and reduce racial healthcare disparities, researchers said.

Explore further: 'Beach body' ads investigated after outcry in Britain

Related Stories

Lower-cost hospital care is not always lower in quality

Feb 22, 2010

The costs that hospitals incur in treating patients vary widely and do not appear to be strongly associated either with the quality of care patients receive or their risk of dying within 30 days, according to a report in ...

Recommended for you

Dutch DSM posts Q1 slump

Apr 29, 2015

Dutch pharmaceutical group DSM posted a 70 million euro first quarter net loss Wednesday despite an 11 percent jump in sales, boosted by higher animal nutrition volumes and favourable exchange rates.

New meds help drugmakers weather strong dollar, other issues

Apr 28, 2015

Revenue from important new medicines for various cancers, hepatitis C and more helped top U.S. drugmakers weather unfavorable currency exchange rates and other challenges. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.